Identification of the actual states of the occurrence of hepatocellular carcinoma in patients with type 2 diabetes.
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000026246
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subjects who were diagnosed as hepatocellular carcinoma at the age of 25 or less. 2) Subjects who were diagnosed as chronic hepatitis B or chronic hepatitis C. 3) Subjects who were not sutbable to enroll the study by physician in charge.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of several data showed below between HCC-developed and HCC-undeveloped type 2 diabetic patients. 1) gender, age, BMI, abdominal circumference, maximum body weight, treatment of diabetes, hypertension and dislipidemia, history of alcohol 2) blood examination: number of Plates 3) Blood chemistry: Albumin, AST, ALT, T-bil, BUN, s-Cre, GGT, ALP, T-Chol, TG, HDL-C, UA, blood glucose level, HbA1c, glicoalbumin 4) coagulation: prothrombin time
- Secondary Outcome Measures
Name Time Method